Skip to main content
Clinical Trials/NCT02911584
NCT02911584
Completed
Not Applicable

Laparoscopic Sacrocolpopexy Versus POPS in the Surgical Management of Pelvic Organ Prolapse: A Prospective Randomized Trial

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pelvic Organ Prolapse
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment
30
Primary Endpoint
Number of patients with anatomical correction of the prolapse
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This is the first study comparing the laparoscopic sacropexy with Pelvic Organs Prolapse Suspension (POPS) to treat pelvic organ prolapse. This prospective randomized surgical trial is designed to test the clinical and functional effects of the two different laparoscopic procedures in terms of anatomical correction of the prolapse, post-operative and long term morbidity, rate of recurrence and subjective satisfaction of the patient evaluated by a quality of life questionnaire.

Registry
clinicaltrials.gov
Start Date
October 2016
End Date
September 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Valeria Tagliaferri

Medical Doctor

Miulli General Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients who required surgical treatment for symptomatic pelvic organ prolapse stage ≥ 2 with or without stress urinary incontinence

Exclusion Criteria

  • Age \> 70 years
  • Severe cardiovascular or respiratory disease
  • Pregnancy
  • Previous surgical procedure for POP correction

Outcomes

Primary Outcomes

Number of patients with anatomical correction of the prolapse

Time Frame: up to 6 months

Anatomical correction of the prolapse evaluated by gynecological visit

Secondary Outcomes

  • Post operative quality of life(up to 6 months)
  • Rate of recurrence(up to 6 months)

Similar Trials